P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS

Bibliographic Details
Main Authors: H. P. J. Lam, S. Leong, Z. Kirkham, A. Wilson, R. Burt, R. Sellar, A. Fielding, R. Gupta, E. Payne, M. Mansour, P. Kottaridis, A. Khwaja, J. O’Nions
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000845076.68865.45
_version_ 1827332491194662912
author H. P. J. Lam
S. Leong
Z. Kirkham
A. Wilson
R. Burt
R. Sellar
A. Fielding
R. Gupta
E. Payne
M. Mansour
P. Kottaridis
A. Khwaja
J. O’Nions
author_facet H. P. J. Lam
S. Leong
Z. Kirkham
A. Wilson
R. Burt
R. Sellar
A. Fielding
R. Gupta
E. Payne
M. Mansour
P. Kottaridis
A. Khwaja
J. O’Nions
author_sort H. P. J. Lam
collection DOAJ
first_indexed 2024-03-07T17:01:45Z
format Article
id doaj.art-33b5d59d329e4ef491ea42685c8ba2c0
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:01:45Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-33b5d59d329e4ef491ea42685c8ba2c02024-03-03T03:19:39ZengWileyHemaSphere2572-92412022-06-01644644710.1097/01.HS9.0000845076.68865.45202206003-00446P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGSH. P. J. Lam0S. Leong1Z. Kirkham2A. Wilson3R. Burt4R. Sellar5A. Fielding6R. Gupta7E. Payne8M. Mansour9P. Kottaridis10A. Khwaja11J. O’Nions121 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematologyhttp://journals.lww.com/10.1097/01.HS9.0000845076.68865.45
spellingShingle H. P. J. Lam
S. Leong
Z. Kirkham
A. Wilson
R. Burt
R. Sellar
A. Fielding
R. Gupta
E. Payne
M. Mansour
P. Kottaridis
A. Khwaja
J. O’Nions
P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
HemaSphere
title P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
title_full P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
title_fullStr P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
title_full_unstemmed P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
title_short P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
title_sort p547 characteristics and outcomes of patients with acute myeloid leukaemia treated with venetoclax combination therapy real world experience in both frontline and relapsed refractory settings
url http://journals.lww.com/10.1097/01.HS9.0000845076.68865.45
work_keys_str_mv AT hpjlam p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT sleong p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT zkirkham p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT awilson p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT rburt p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT rsellar p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT afielding p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT rgupta p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT epayne p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT mmansour p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT pkottaridis p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT akhwaja p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings
AT jonions p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings